Targeting Cdk5 activity in neuronal degeneration and regeneration

Cellular and Molecular Neurobiology

Volumn 29, Issue 8, 2009, Pages 1073-1080

  Kanungo, Jyotshnabala ^a   Zheng, Ya Li ^a   Amin, Niranjana D ^a   Pant, Harish C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cdk5; Hyperphosphorylation; Neurodegeneration; Neuron regeneration; Tau

Indexed keywords

CALCIUM; CALPAIN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOSKELETON PROTEIN; PROTEIN P35; ENZYME ACTIVATOR; PEPTIDE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CALCIUM CELL LEVEL; CELL FUNCTION; CELL LOSS; CELL REGENERATION; HUMAN; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; MOUSE; NERVE DEGENERATION; NERVE REGENERATION; PHYSIOLOGY;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; ENZYME ACTIVATORS; ENZYME INDUCTION; MICE; NERVE DEGENERATION; NERVE REGENERATION; PEPTIDES;

EID: 77049099632     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9410-6     Document Type: Review

References (86)

1. MK Ahlijanian NX Barrezueta RD Williams A Jakowski KP Kowsz S McCarthy T Coskran A Carlo PA Seymour JE Burkhardt, et al. 2000 Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 Proc Natl Acad Sci USA 97 2910 2915 10.1073/pnas.040577797 10.1073/pnas.040577797 10706614 1:CAS:528:DC%2BD3cXitVahtrY%3D (Pubitemid 30159271)
2. A Alvarez R Toro A Caceres RB Maccioni 1999 Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death FEBS Lett 459 421 426 10.1016/S0014-5793(99)01279-X 10.1016/S0014-5793(99) 01279-X 10526177 1:CAS:528:DyaK1MXmvVKjsLc%3D (Pubitemid 29467380)
3. C Andorfer CM Acker Y Kress PR Hof K Duff P Davies 2005 Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms J Neurosci 25 5446 5454 10.1523/JNEUROSCI.4637-04.2005 10.1523/JNEUROSCI.4637-04.2005 15930395 1:CAS:528:DC%2BD2MXlt1ynsro%3D (Pubitemid 40770926)
4. M Angelo F Plattner KP Giese 2006 Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory J Neurochem 99 353 370 10.1111/j.1471-4159.2006. 04040.x 10.1111/j.1471-4159.2006.04040.x 17029592 1:CAS:528:DC%2BD28XhtF2rsLvN (Pubitemid 44477194)
5. SC Apfel 2000 Neurotrophic factors and pain Clin J Pain 16 S7 S11 10870734 1:STN:280:DC%2BD3cvpt1yjsg%3D%3D
6. T Chae YT Kwon R Bronson P Dikkes E Li LH Tsai 1997 Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality Neuron 18 29 42 10.1016/S0896-6273(01)80044-1 10.1016/S0896-6273(01)80044-1 9010203 1:CAS:528:DyaK2sXpslKktQ%3D%3D (Pubitemid 27053828)
7. EC Cheung RS Slack 2004 Emerging role for ERK as a key regulator of neuronal apoptosis Sci STKE 2004 PE45 10.1126/stke.2512004pe45 10.1126/stke.2512004pe45 15383672
8. ZH Cheung K Gong NY Ip 2008 Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2 J Neurosci 28 4872 4877 10.1523/JNEUROSCI.0689-08.2008 10.1523/JNEUROSCI.0689-08.2008 18463240 1:CAS:528:DC%2BD1cXlvFersbc%3D
9. S Cicero K Herrup 2005 Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation J Neurosci 25 9658 9668 10.1523/JNEUROSCI.1773-05.2005 10.1523/JNEUROSCI.1773-05.2005 16237170 1:CAS:528:DC%2BD2MXht1WqsrnJ (Pubitemid 41510906)
10. SJ Crocker P Liston H Anisman CJ Lee PD Smith N Earl CS Thompson DS Park RG Korneluk GS Robertson 2003 Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice Neurobiol Dis 12 150 161 10.1016/S0969-9961(02)00020-7 10.1016/S0969-9961(02)00020-7 12667469 1:CAS:528:DC%2BD3sXitlWgurY%3D (Pubitemid 36349406)
11. SJ Crocker PD Smith V Jackson-Lewis WR Lamba SP Hayley E Grimm SM Callaghan RS Slack E Melloni S Przedborski, et al. 2003 Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease J Neurosci 23 4081 4091 12764095 1:CAS:528:DC%2BD3sXktFKgurw%3D
12. JC Cruz LH Tsai 2004 A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease Curr Opin Neurobiol 14 390 394 10.1016/j.conb.2004.05. 002 10.1016/j.conb.2004.05.002 15194121 1:CAS:528:DC%2BD2cXkvV2ns70%3D (Pubitemid 38759871)
13. JC Cruz HC Tseng JA Goldman H Shih LH Tsai 2003 Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles Neuron 40 471 483 10.1016/S0896-6273(03)00627-5 10.1016/S0896-6273(03)00627-5 14642273 1:CAS:528:DC%2BD3sXptVylurk%3D (Pubitemid 37494698)
14. JC Cruz D Kim LY Moy MM Dobbin X Sun RT Bronson LH Tsai 2006 p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo J Neurosci 26 10536 10541 10.1523/JNEUROSCI.3133-06.2006 10.1523/JNEUROSCI.3133-06.2006 17035538 1:CAS:528:DC%2BD28XhtFegurzJ (Pubitemid 44564604)
15. R Dhavan LH Tsai 2001 A decade of CDK5 Nat Rev Mol Cell Biol 2 749 759 10.1038/35096019 10.1038/35096019 11584302 1:CAS:528:DC%2BD3MXnvVajsLg%3D (Pubitemid 33679837)
16. G Drewes 2004 MARKing tau for tangles and toxicity Trends Biochem Sci 29 548 555 10.1016/j.tibs.2004.08.001 10.1016/j.tibs.2004.08.001 15450610 1:CAS:528:DC%2BD2cXnvVOhs7s%3D (Pubitemid 39265172)
17. JA Fernandez L Rojo RO Kuljis RB Maccioni 2008 The damage signals hypothesis of Alzheimer's disease pathogenesis J Alzheimers Dis 14 329 333 18599959 1:CAS:528:DC%2BD1cXns1amtrw%3D
18. A Fischer F Sananbenesi J Spiess J Radulovic 2003 Cdk5: a novel role in learning and memory Neurosignals 12 200 208 10.1159/000074621 10.1159/000074621 14673206 1:CAS:528:DC%2BD3sXpslOis74%3D (Pubitemid 37548234)
19. A Fischer F Sananbenesi PT Pang B Lu LH Tsai 2005 Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory Neuron 48 825 838 10.1016/j.neuron.2005.10.033 10.1016/j.neuron.2005.10.033 16337919 1:CAS:528:DC%2BD2MXhtleksL7F (Pubitemid 41759432)
20. KA Gallo GL Johnson 2002 Mixed-lineage kinase control of JNK and p38 MAPK pathways Nat Rev Mol Cell Biol 3 663 672 10.1038/nrm906 10.1038/nrm906 12209126 1:CAS:528:DC%2BD38Xmslagu7o%3D (Pubitemid 34987787)
21. M Geraerts O Krylyshkina Z Debyser V Baekelandt 2007 Concise review: therapeutic strategies for Parkinson disease based on the modulation of adult neurogenesis Stem Cells 25 263 270 10.1634/stemcells.2006-0364 10.1634/stemcells.2006-0364 17082225 1:CAS:528:DC%2BD2sXivVOlsbs%3D (Pubitemid 46232779)
22. CG Gross 2000 Neurogenesis in the adult brain: death of a dogma Nat Rev Neurosci 1 67 73 10.1038/35036235 10.1038/35036235 11252770 1:CAS:528: DC%2BD3MXivVSjs7o%3D
23. C Haass DJ Selkoe 2007 Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat Rev Mol Cell Biol 8 101 112 10.1038/nrm2101 10.1038/nrm2101 17245412 1:CAS:528:DC%2BD2sXotFKmtw%3D%3D (Pubitemid 46432529)
24. JL Hallows K Chen RA DePinho I Vincent 2003 Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice J Neurosci 23 10633 10644 14627648 1:CAS:528:DC%2BD3sXpsFGjurs%3D
25. T Harada T Morooka S Ogawa E Nishida 2001 ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 Nat Cell Biol 3 453 459 10.1038/35074516 10.1038/35074516 11331872 1:CAS:528:DC%2BD3MXjsFCksr8%3D (Pubitemid 32422080)
26. J Hardy DJ Selkoe 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 353 356 10.1126/science.1072994 10.1126/science.1072994 12130773 1:CAS:528: DC%2BD38Xls1Cju7s%3D (Pubitemid 34790756)
27. M Hashiguchi T Saito S Hisanaga T Hashiguchi 2002 Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau J Biol Chem 277 44525 44530 10.1074/jbc.M207426200 10.1074/jbc.M207426200 12226093 1:CAS:528:DC%2BD38Xos1akur0%3D (Pubitemid 36157887)
28. N Heintz 1993 Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem Sci 18 157 159 10.1016/0968-0004(93)90103-T 10.1016/0968-0004(93)90103-T 8328013 1:STN:280:DyaK3szhvVartA%3D%3D (Pubitemid 23142567)
29. NM Hooper AJ Turner 2008 A new take on prions: preventing Alzheimer's disease Trends Biochem Sci 33 151 155 10.1016/j.tibs.2008.01.004 10.1016/j.tibs.2008.01.004 18343669 1:CAS:528:DC%2BD1cXktlCkur0%3D
30. K Iijima K Ando S Takeda Y Satoh T Seki S Itohara P Greengard Y Kirino AC Nairn T Suzuki 2000 Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5 J Neurochem 75 1085 1091 10.1046/j.1471-4159.2000.0751085.x 10.1046/j.1471-4159.2000.0751085.x 10936190 1:CAS:528:DC%2BD3cXmtFyrs74%3D (Pubitemid 30660497)
31. K Imahori T Uchida 1997 Physiology and pathology of tau protein kinases in relation to Alzheimer's disease J Biochem 121 179 188 9089387 1:CAS:528:DyaK2sXislSrsLs%3D
32. T Ishizawa N Sahara K Ishiguro J Kersh E McGowan J Lewis M Hutton DW Dickson SH Yen 2003 Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice Am J Pathol 163 1057 1067 12937146 1:CAS:528:DC%2BD3sXnsVCisr0%3D
33. GV Johnson WH Stoothoff 2004 Tau phosphorylation in neuronal cell function and dysfunction J Cell Sci 117 5721 5729 10.1242/jcs.01558 10.1242/jcs.01558 15537830 1:CAS:528:DC%2BD2MXlvFShtw%3D%3D (Pubitemid 40123939)
34. S Kesavapany KF Lau S Ackerley SJ Banner SJ Shemilt JD Cooper PN Leigh CE Shaw DM McLoughlin CC Miller 2003 Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase J Neurosci 23 4975 4983 12832520 1:CAS:528:DC%2BD3sXltlentr0%3D
35. S Kesavapany N Amin YL Zheng R Nijhara H Jaffe R Sihag JS Gutkind S Takahashi A Kulkarni P Grant HC Pant 2004 p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons J Neurosci 24 4421 4431 10.1523/JNEUROSCI.0690-04.2004 10.1523/JNEUROSCI.0690-04.2004 15128856 1:CAS:528:DC%2BD2cXktFCjtLY%3D (Pubitemid 38608153)
36. S Kesavapany TK Pareek YL Zheng N Amin JS Gutkind W Ma AB Kulkarni P Grant HC Pant 2006 Neuronal nuclear organization is controlled by cyclin-dependent kinase 5 phosphorylation of Ras Guanine nucleotide releasing factor-1 Neurosignals 15 157 173 10.1159/000095130 10.1159/000095130 16921254 1:CAS:528:DC%2BD2sXmt1Squr8%3D (Pubitemid 46895637)
37. S Kesavapany V Patel YL Zheng TK Pareek M Bjelogrlic W Albers N Amin H Jaffe JS Gutkind MJ Strong, et al. 2007 Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons Mol Biol Cell 18 3645 3655 10.1091/mbc.E07-03-0237 10.1091/mbc.E07-03- 0237 17626162 1:CAS:528:DC%2BD2sXhtVWnt7fE (Pubitemid 47378701)
38. J Ko S Humbert RT Bronson S Takahashi AB Kulkarni E Li LH Tsai 2001 p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment J Neurosci 21 6758 6771 11517264 1:CAS:528:DC%2BD3MXmt1Wisrs%3D
39. MS Lee YT Kwon M Li J Peng RM Friedlander LH Tsai 2000 Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 360 364 10.1038/35012636 10.1038/35012636 10830966 1:CAS:528:DC%2BD3cXjs1Kqsrk%3D (Pubitemid 30337070)
40. M Li VO Ona C Guegan M Chen V Jackson-Lewis LJ Andrews AJ Olszewski PE Stieg JP Lee S Przedborski RM Friedlander 2000 Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model Science 288 335 339 10.1126/science.288.5464.335 10.1126/science.288.5464.335 10764647 1:CAS:528:DC%2BD3cXislertbc%3D (Pubitemid 30226195)
41. Y Li L Liu SW Barger WS Griffin 2003 Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway J Neurosci 23 1605 1611 12629164 1:CAS:528:DC%2BD3sXjtFylt7c%3D
42. RB Maccioni JP Munoz L Barbeito 2001 The molecular bases of Alzheimer's disease and other neurodegenerative disorders Arch Med Res 32 367 381 10.1016/S0188-4409(01)00316-2 10.1016/S0188-4409(01)00316-2 11578751 1:CAS:528:DC%2BD3MXnslKhtrk%3D (Pubitemid 32918139)
43. A McShea HG Lee RB Petersen G Casadesus I Vincent NJ Linford JO Funk RA Shapiro MA Smith 2007 Neuronal cell cycle re-entry mediates Alzheimer disease-type changes Biochim Biophys Acta 1772 467 472 17095196 1:CAS:528:DC%2BD2sXjtVahu74%3D
44. M Meyerson GH Enders CL Wu LK Su C Gorka C Nelson E Harlow LH Tsai 1992 A family of human cdc2-related protein kinases EMBO J 11 2909 2917 1639063 1:CAS:528:DyaK3sXkt1emsLc%3D
45. G Morfini G Szebenyi R Elluru N Ratner ST Brady 2002 Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility EMBO J 21 281 293 10.1093/emboj/21.3.281 10.1093/emboj/21.3.281 11823421 1:CAS:528:DC%2BD38XhsVSnsro%3D (Pubitemid 34137290)
46. G Morfini G Szebenyi H Brown HC Pant G Pigino S DeBoer U Beffert ST Brady 2004 A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons EMBO J 23 2235 2245 10.1038/sj.emboj.7600237 15152189 1:CAS:528:DC%2BD2cXksV2htrw%3D (Pubitemid 38833233)
47. N Morita S Kiryu H Kiyama 1996 p53-independent cyclin G expression in a group of mature neurons and its enhanced expression during nerve regeneration J Neurosci 16 5961 5966 8815878 1:CAS:528:DyaK28XntlartLs%3D
48. Z Nagy 2000 Cell cycle regulatory failure in neurones: causes and consequences Neurobiol Aging 21 761 769 10.1016/S0197-4580(00)00223-2 10.1016/S0197-4580(00)00223-2 11124420 1:CAS:528:DC%2BD3cXovFGqu74%3D
49. S Naska KJ Park GE Hannigan S Dedhar FD Miller DR Kaplan 2006 An essential role for the integrin-linked kinase-glycogen synthase kinase-3 beta pathway during dendrite initiation and growth J Neurosci 26 13344 13356 10.1523/JNEUROSCI.4462-06.2006 10.1523/JNEUROSCI.4462-06.2006 17182785 1:CAS:528:DC%2BD2sXjsFalug%3D%3D (Pubitemid 46011645)
50. MD Nguyen WE Mushynski JP Julien 2002 Cycling at the interface between neurodevelopment and neurodegeneration Cell Death Differ 9 1294 1306 10.1038/sj.cdd.4401108 10.1038/sj.cdd.4401108 12478466 1:CAS:528: DC%2BD38XpsVSrsb8%3D (Pubitemid 36097699)
51. T Ohshima JM Ward CG Huh G Longenecker Veeranna HC Pant RO Brady LJ Martin AB Kulkarni 1996 Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death Proc Natl Acad Sci USA 93 11173 11178 10.1073/pnas.93.20.11173 10.1073/pnas.93.20.11173 8855328 1:CAS:528:DyaK28XmtVOrurc%3D (Pubitemid 26333137)
52. JO Ojala EM Sutinen A Salminen T Pirttila 2008 Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells J Neuroimmunol 205 86 93 10.1016/j.jneuroim.2008.09.012 10.1016/j.jneuroim.2008.09.012 18947885 1:CAS:528:DC%2BD1cXhsVWrsbzN
53. K Okamoto D Beach 1994 Cyclin G is a transcriptional target of the p53 tumor suppressor protein EMBO J 13 4816 4822 7957050 1:CAS:528: DyaK2MXhvF2iu7w%3D
54. C Otth II Concha T Arendt J Stieler R Schliebs C Gonzalez-Billault RB Maccioni 2002 AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576 J Alzheimers Dis 4 417 430 12446973 1:CAS:528: DC%2BD38XovVGmt7w%3D
55. GN Patrick L Zukerberg M Nikolic S de la Monte P Dikkes LH Tsai 1999 Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 615 622 10.1038/45159 10.1038/45159 10604467 1:CAS:528:DC%2BD3cXjsVGq
56. H Patzke LH Tsai 2002 Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29 J Biol Chem 277 8054 8060 10.1074/jbc.M109645200 10.1074/jbc.M109645200 11784720 1:CAS:528:DC%2BD38XitFymsL0%3D (Pubitemid 34968258)
57. CJ Phiel CA Wilson VM Lee PS Klein 2003 GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides Nature 423 435 439 10.1038/nature01640 10.1038/nature01640 12761548 1:CAS:528:DC%2BD3sXjvFaltLY%3D (Pubitemid 36626994)
58. RA Quintanilla DI Orellana C Gonzalez-Billault RB Maccioni 2004 Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway Exp Cell Res 295 245 257 10.1016/j.yexcr.2004. 01.002 10.1016/j.yexcr.2004.01.002 15051507 1:CAS:528:DC%2BD2cXis1Wgs7w%3D (Pubitemid 38407361)
59. LE Rojo JA Fernandez AA Maccioni JM Jimenez RB Maccioni 2008 Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease Arch Med Res 39 1 16 10.1016/j.arcmed.2007.10.001 10.1016/j.arcmed.2007.10.001 18067990 1:CAS:528:DC%2BD2sXhsVSmtbvM (Pubitemid 350192021)
60. P Rudrabhatla YL Zheng ND Amin S Kesavapany W Albers HC Pant 2008 Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein J Biol Chem 283 26737 26747 10.1074/jbc.M801633200 10.1074/jbc.M801633200 18635547 1:CAS:528: DC%2BD1cXhtFejtrrI
61. H Sato I Nishimoto M Matsuoka 2002 Ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl Biochim Biophys Acta 1574 157 163 11955625 1:CAS:528:DC%2BD38XktVKgtbw%3D
62. X Shan L Chi M Bishop C Luo L Lien Z Zhang R Liu 2006 Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease-like mice Stem Cells 24 1280 1287 10.1634/stemcells.2005-0487 10.1634/stemcells. 2005-0487 16424396 1:CAS:528:DC%2BD28XhtFGhu7fP (Pubitemid 44464697)
63. P Sharma Veeranna M Sharma ND Amin RK Sihag P Grant N Ahn AB Kulkarni HC Pant 2002 Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway J Biol Chem 277 528 534 10.1074/jbc.M109324200 10.1074/jbc.M109324200 11684694 1:CAS:528: DC%2BD38XjslGnsg%3D%3D (Pubitemid 34952088)
64. SB Shelton GV Johnson 2004 Cyclin-dependent kinase-5 in neurodegeneration J Neurochem 88 1313 1326 15009631 1:CAS:528:DC%2BD2cXivVCit7w%3D
65. KT Shetty WT Link HC Pant 1993 Cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization Proc Natl Acad Sci USA 90 6844 6848 10.1073/pnas.90.14.6844 10.1073/pnas.90.14.6844 8341707 1:CAS:528:DyaK3sXlvFyhs7o%3D
66. M Slevin J Krupinski 2008 Cyclin-dependent kinase-5 targeting for ischaemic stroke Curr Opin Pharmacol 9 119 124 10.1016/j.coph.2008.10.003 18983942 1:CAS:528:DC%2BD1MXjsFahsbs%3D
67. R Sultana DA Butterfield 2007 Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment Neurochem Res 32 655 662 10.1007/s11064-006-9123-x 10.1007/s11064-006-9123-x 17006763 1:CAS:528:DC%2BD2sXjtlynu7k%3D (Pubitemid 46481287)
68. KH Sun Y de Pablo F Vincent EO Johnson AK Chavers K Shah 2008 Novel genetic tools reveal Cdk5's major role in golgi fragmentation in Alzheimer's disease Mol Biol Cell 19 3052 3069 10.1091/mbc.E07-11-1106 10.1091/mbc.E07-11- 1106 18480410 1:CAS:528:DC%2BD1cXoslWitbs%3D
69. S Takahashi T Saito S Hisanaga HC Pant AB Kulkarni 2003 Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules J Biol Chem 278 10506 10515 10.1074/jbc.M211964200 10.1074/jbc.M211964200 12536148 1:CAS:528: DC%2BD3sXitVCrtbg%3D (Pubitemid 36800318)
70. JA Thomson J Itskovitz-Eldor SS Shapiro MA Waknitz JJ Swiergiel VS Marshall JM Jones 1998 Embryonic stem cell lines derived from human blastocysts Science 282 1145 1147 10.1126/science.282.5391.1145 10.1126/science.282.5391. 1145 9804556 1:CAS:528:DyaK1cXntleisLg%3D
71. T Town J Zolton R Shaffner B Schnell R Crescentini Y Wu J Zeng A DelleDonne D Obregon J Tan M Mullan 2002 p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro J Neurosci Res 69 362 372 10.1002/jnr.10299 10.1002/jnr.10299 12125077 1:CAS:528:DC%2BD38XlslKks7k%3D (Pubitemid 34809485)
72. C Van den Haute K Spittaels J Van Dorpe R Lasrado K Vandezande I Laenen H Geerts F Van Leuven 2001 Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice Neurobiol Dis 8 32 44 10.1006/nbdi.2000.0333 10.1006/nbdi.2000.0333 11162238 1:CAS:528:DC%2BD3MXpvVSrsw%3D%3D (Pubitemid 32171816)
73. B Voigt M Krug C Schachtele F Totzke A Hilgeroth 2008 Probing novel 1-aza-9-oxafluorenes as selective GSK-3beta inhibitors ChemMedChem 3 120 126 10.1002/cmdc.200700175 10.1002/cmdc.200700175 18000938 1:CAS:528: DC%2BD1cXlt1Kqs7Y%3D
74. CX Wang JH Song DK Song VW Yong A Shuaib C Hao 2006 Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2 Cell Death Differ 13 1203 1212 10.1038/sj.cdd.4401804 10.1038/sj.cdd.4401804 16273078 1:CAS:528:DC%2BD28Xls1Khsbc%3D (Pubitemid 43905600)
75. Y Wen SH Yang R Liu EJ Perez AM Brun-Zinkernagel P Koulen JW Simpkins 2007 Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats Biochim Biophys Acta 1772 473 483 17113760 1:CAS:528:DC%2BD2sXjtVahu78%3D
76. Z Yang Q Zhu K Luo Q Zhou 2001 The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription Nature 414 317 322 10.1038/35104575 10.1038/35104575 11713532 1:CAS:528:DC%2BD3MXovFGis78%3D (Pubitemid 33097809)
77. L Yang S Sugama RP Mischak M Kiaei N Bizat E Brouillet TH Joh MF Beal 2004 A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo Neurobiol Dis 17 250 259 10.1016/j.nbd.2004.07. 021 10.1016/j.nbd.2004.07.021 15474362 1:CAS:528:DC%2BD2cXotlSlsbc%3D (Pubitemid 39345780)
78. K Yoshimi YR Ren T Seki M Yamada H Ooizumi M Onodera Y Saito S Murayama H Okano Y Mizuno H Mochizuki 2005 Possibility for neurogenesis in substantia nigra of parkinsonian brain Ann Neurol 58 31 40 10.1002/ana.20506 10.1002/ana.20506 15912513 (Pubitemid 40962458)
79. J Yuan BA Yankner 2000 Apoptosis in the nervous system Nature 407 802 809 10.1038/35037739 10.1038/35037739 11048732 1:CAS:528:DC%2BD3cXnsFWrsbY%3D (Pubitemid 30780744)
80. A Zauberman A Lupo M Oren 1995 Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites Oncogene 10 2361 2366 7784084 1:CAS:528:DyaK2MXmsFCgsLc%3D
81. M Zhao S Momma K Delfani M Carlen RM Cassidy CB Johansson H Brismar O Shupliakov J Frisen AM Janson 2003 Evidence for neurogenesis in the adult mammalian substantia nigra Proc Natl Acad Sci USA 100 7925 7930 10.1073/pnas.1131955100 10.1073/pnas.1131955100 12792021 1:CAS:528: DC%2BD3sXlt1WqtrY%3D (Pubitemid 36760071)
82. C Zhao W Deng FH Gage 2008 Mechanisms and functional implications of adult neurogenesis Cell 132 645 660 10.1016/j.cell.2008.01.033 10.1016/j.cell.2008.01.033 18295581 1:CAS:528:DC%2BD1cXivVagtrY%3D (Pubitemid 351253687)
83. YL Zheng BS Li ND Amin W Albers HC Pant 2002 A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells Eur J Biochem 269 4427 4434 10.1046/j.1432-1033.2002.03133.x 10.1046/j.1432-1033.2002.03133.x 12230554 1:CAS:528:DC%2BD38XptlaqsrY%3D
84. YL Zheng S Kesavapany M Gravell RS Hamilton M Schubert N Amin W Albers P Grant HC Pant 2005 A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons EMBO J 24 209 220 10.1038/sj.emboj.7600441 10.1038/sj.emboj.7600441 15592431 1:CAS:528:DC%2BD2MXlvVKmug%3D%3D (Pubitemid 40188478)
85. YL Zheng BS Li J Kanungo S Kesavapany N Amin P Grant HC Pant 2007 Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival Mol Biol Cell 18 404 413 10.1091/mbc.E06-09-0851 10.1091/mbc.E06-09- 0851 17108320 1:CAS:528:DC%2BD2sXhsFarsLs%3D (Pubitemid 46213211)
86. Z Zhu Q Zhang Z Yu L Zhang D Tian S Zhu B Bu M Xie W Wang 2007 Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo Glia 55 546 558 10.1002/glia.20476 10.1002/glia.20476 17243097 (Pubitemid 46383184)